◼ Archived
Business
🔮 fades ✓
Ipsen to Buy Kartos Therapeutics for Up to $1.75 Billion
French biotech company Ipsen is acquiring Kartos Therapeutics for up to $1.75 billion to expand its blood cancer pipeline.
1 trends tracked about this subject — the full history, oldest to newest below.
French biotech company Ipsen is acquiring Kartos Therapeutics for up to $1.75 billion to expand its blood cancer pipeline.